Table 2. The associations between use of antithrombotics with aggravation of hemorrhagic transformation by multivariate logistic regression analysis in patients with hemorrhagic infarction (N = 150).

	Model 1	p	Model 2	p
Anti-thrombotics before HT		0.467		0.475
No med	Ref		Ref
Antiplatelet	0.489 (0.117–2.049)	0.328	0.508 (0.120–2.147)	0.357
Warfarin	0.965 (0.199–4.679)	0.965	1.021 (0.206–5.053)	0.980
Anti-thrombotics after HT		0.038		0.041
No med	Ref		Ref
Antiplatelet	0.150 (0.035–0.642)	0.011	0.153 (0.036–0.657)	0.012
Warfarin	0.517 (0.124–2.152)	0.365	1.186 (0.375–3.755)	0.771

Aggravation of HT; Model 1: Adjusted by age and initial NIHSS. Model 2: Adjusted by age, initial NIHSS, and thrombolysis.

END; adjusted by age, initial NIHSS and thrombolysis.